EpiBone: Funding, Investors & Team (Oct 2026)
EpiBone is a revolutionary bone reconstruction company that allows patients to “grow their own bone”. EpiBone’s pioneering technology utilizes a scan of the patient’s bone defect and the patient’s own stem cells to construct and cultivate a defect-specific autologous-like bone graft. EpiBone is strategically positioned to provide a superior bone graft that will provide exact defect repair, a simplified surgical procedure, improved bone formation and regeneration, and shorter recovery times, without the complications of foreign body implantation, to the over 900,000 patients who undergo bone-related surgeries each year.
EpiBone has raised $22.8M across 3 funding rounds on record, the most recent an undisclosed round of $4.3M announced in Oct 2025.
That round is below the $8.4M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
EpiBone Company Profile and Key Stats
Latest funding round on record: Oct 2025.
EpiBone Funding Rounds
1 of 3 rounds was announced without a disclosed amount and is excluded from the total.
EpiBone raised $18.5M in an undisclosed round announced in Dec 2022.
1.9 years later, an undisclosed round was announced in Nov 2024 with no disclosed amount.
11 months later, an undisclosed round of $4.3M was announced in Oct 2025.
EpiBone Founders and Leadership Team
Contact details for the EpiBone team: 1 of 1 has an email address on file.
Start 14-day free trial →EpiBone Funding Compared to Other Biotechnology Startups
EpiBone's latest round of $4.3M is below the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like EpiBone in Biotechnology and Jersey City
Companies Similar to EpiBone
Prolific Machines is a biotech company located in San Francisco, California, that was established in 2020. It…
Altay Therapeutics is a biotech company focused on finding and discovering small molecule therapies for…
Kallyope, we believe that the gut is the gateway to our internal world. Containing millions of neurons, the…
Astrocyte Pharmaceuticals is a drug development company that helps in the recovery and well-being of brain…
Tiny Health offers a gut health test specifically designed for mothers and babies aged 0 to 3 years.…
Junevity is dedicated to using cutting-edge transcription factor medicines to combat age-related diseases.…
Arkea Bio creates technology aimed at reducing greenhouse gas (GHG) emissions in the agricultural sector.
Serán is a contract development and manufacturing organization providing a comprehensive suite of…
Precision’s goal is to provide breakthrough treatments for the one billion patients worldwide suffering from…
Enveda is a biotechnology company that utilizes AI-powered tools to explore and characterize molecules from…
Avery Therapeutics, Inc. is a company dedicated to developing tissue engineered therapeutics to treat…
EpiBone Funding FAQs
What does EpiBone do?
EpiBone is a revolutionary bone reconstruction company that allows patients to “grow their own bone”. EpiBone’s pioneering technology utilizes a scan of the patient’s bone defect and the patient’s own stem cells to construct and cultivate a defect-specific autologous-like bone graft. EpiBone is strategically positioned to provide a superior bone graft that will provide exact defect repair, a simplified surgical procedure, improved bone formation and regeneration, and shorter recovery times, without the complications of foreign body implantation, to the over 900,000 patients who undergo bone-related surgeries each year.
How much funding has EpiBone raised?
EpiBone has raised $22.8M across 3 rounds on record. The most recent is an undisclosed round of $4.3M announced in Oct 2025.
When did EpiBone last raise funding?
EpiBone's most recent funding round on record is an undisclosed round of $4.3M, announced in Oct 2025.
Who founded EpiBone?
FundedIQ lists Nina Tandon (Founder) at EpiBone.
Where is EpiBone headquartered?
EpiBone is based in Jersey City, New Jersey, United States.
How many employees does EpiBone have?
EpiBone is in the 11-50 employee band.
How does EpiBone's funding compare to other Biotechnology startups?
EpiBone's latest round of $4.3M is below the $8.4M median round size for Biotechnology companies on FundedIQ across 4,185 tracked companies over the last two years.
About FundedIQ's EpiBone Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for EpiBone is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.
Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.